Logo Lucerna-Chem
+41 41 420 9636

Regulatory Status

Article Status


DBPR112


Catalog Number Pack Size List Price* Promo Price* Quantity
HY-128778-5MG 5 mg 537,00 456,50 Add
HY-128778-10MMO 10 mM * 1 mL 630,00 535,50 Add
HY-128778-10MG 10 mg 881,00 748,90 Add
HY-128778-25MG 25 mg 1'814,00 1'541,90 Add
HY-128778-50MG 50 mg 2'803,00 2'382,60 Add
HY-128778-100MG 100 mg 4'177,00 3'550,50 Add

* CHF, excl. 7.7% VAT and shipping costs


Product Description

DBPR112 is an orally active furanopyrimidine-based EGFR inhibitor with IC50s of 15 nM and 48 nM for EGFRWT and EGFRL858R/T790M, respectively. DBPR112 can occupy the ATP-binding site. DBPR112 has significant antitumor efficacy.

Category Biochemicals
Supplier MedChem Express
Application Cancer-Kinase/protease
Regulatory Status RUO
Format Solubility: DMSO : 250 mg/mL (468.50 mM; Need ultrasonic) ; H2O : < 0.1 mg/mL (insoluble)
Grade Clinical information: Phase 1
Purity 98.07%
Molecular Formula C32H31N5O3
Molecular Weight 533.62
CAS-Number [1226549-49-0]
Storage Conditions Powder -20°C 3 years, 4°C 2 years; In solvent -80°C 6 months, -20°C 1 month
Product Line Research
Tech. Data Sheet View datasheet
Link To Supplier http://www.medchemexpress.com
Material Safety Data Sheet Download PDF
Call us

Customer Support
T +41 41 420 96 36
F +41 41 420 96 56
info@lucerna-chem.ch

Business Hours
From Monday through Friday
08:00 – 12:00
13:00 – 17:00

Ask us

Technical Support
tech@lucerna-chem.ch

Business Development
business.dev@lucerna-chem.ch

Postal address
Lucerna-Chem AG
Abendweg 18
CH-6006 Luzern

Newsletter













If you have already subscribed to our newsletter and would like to update your details or cancel it, please click here.


© Copyright 2021 Lucerna-Chem AG, Switzerland